Differential exposure biomarker levels among cigarette smokers and smokeless tobacco consumers in the National Health and Nutrition Examination Survey 1999â€"2008

Biomarkers

Volumn 16, Issue 3, 2011, Pages 222-235

  Naufal, Ziad S ^a   Marano, Kristin M ^a   Kathman, Steven J ^a   Wilson, Cody L ^a  

^a R J REYNOLDS TOBACCO COMPANY   (United States)

Author keywords

chewing tobacco; mainstream smoke; NHANES; snuff

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ACRYLAMIDE; AROMATIC HYDROCARBON; COTININE; CREATININE; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; AGED; BLOOD LEVEL; CIGARETTE SMOKING; CONSUMER; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; HEALTH SURVEY; HUMAN; MALE; NICOTINE REPLACEMENT THERAPY; REVIEW; SMOKELESS TOBACCO;

ADULT; AGED; BIOLOGICAL MARKERS; BUTANONES; COTININE; FEMALE; HUMANS; HYDROCARBONS, HALOGENATED; MALE; METALS; MIDDLE AGED; NUTRITION SURVEYS; POLYCYCLIC HYDROCARBONS, AROMATIC; SMOKING; TOBACCO, SMOKELESS; VOLATILE ORGANIC COMPOUNDS; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 79955082420     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.546013     Document Type: Review

References (56)

1. Albertini R, Bird M, Doerrer N, Needham L, Robison S, Sheldon L, Zenick H. (2006). Te use of biomonitoring data in exposure and human health risk assessments. Environ Health Perspect 114:1755-1762. (Pubitemid 44732107)
2. Alexandrie AK, Warholm M, Carstensen U, Axmon A, Hagmar L, Levin JO, Ostman C, Rannug A. (2000). CYP1A1 and GSTM1 polymorphisms afect urinary 1-hydroxypyrene levels after PAH exposure. Carcinogenesis 21:669-676. (Pubitemid 30214023)
3. Apostoli P, Neri G, Lucas D, Manno M, Berthou F. (2003). Infuence of genetic polymorphisms of CYP1A1 and GSTM1 on the urinary levels of 1-hydroxypyrene. Toxicol Lett 144:27-34. (Pubitemid 36957954)
4. Benowitz NL, Jacob P 3rd, Yu L. (1989). Daily use of smokeless tobacco: systemic efects. Ann Intern Med 111:112-116. (Pubitemid 19180321)
5. Buratti M, Pellegrino O, Brambilla G, Colombi A. (2000). Urinary excretion of 1-hydroxypyrene as a biomarker of exposure to polycyclic aromatic hydrocarbons from diferent sources. Biomarkers 5:368-381.
6. CDC (Centers for Disease Control and Prevention). (2009a). National Health and Nutrition Examination Survey, What's New Archive, July 2009. Available at: http://www.cdc.gov/nchs/nhanes/archive-new-nhanes.htm [accessed May 2010]
7. CDC (Centers for Disease Control and Prevention). (2009b). Fourth national report on human exposure to environmental chemicals. Department of Health and Human Services. Available at: http://www.cdc.gov/exposurereport/pdf/ FourthReport.pdf [accessed May 2010]
8. CDC (Centers for Disease Control and Prevention). (2010a). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Available at: http://www.cdc.gov/ nchs/nhanes.htm [accessed May 2010]
9. CDC (Centers for Disease Control and Prevention). (2010b). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol). Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Available: http://www.cdc.gov/nchs/nhanes.htm [accessed May 2010]
10. Diekmann J, Wittig A, Stabbert R. (2008). Gas chromatographic-mass spectrometric analysis of acrylamide and acetamide in cigarette mainstream smoke after on-column injection. J Chromatogr Sci 46:659-663.
11. Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt RD. (2004). Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users. Addict Behav 29:349-355. (Pubitemid 38083249)
12. Ellingsen DG, Tomassen Y Rustad P, Molander P, Aaseth J. (2009). Te time-trend and the relation between smoking and circulating selenium concentrations in Norway. J Trace Elem Med Biol 23:107-115.
13. Gebel TW, Suchenwirth RH, Bolten C, Dunkelberg HH. (1998). Human biomonitoring of arsenic and antimony in case of an elevated geogenic exposure. Environ Health Perspect 106:33-39. (Pubitemid 28122015)
14. Hajimiragha H, Ewers U, Brockhaus A, Boettger A. (1989). Levels of benzene and other volatile aromatic compounds in the blood of non-smokers and smokers. Int Arch Occup Environ Health 61:513-518. (Pubitemid 19248080)
15. Hecht SS. (2002). Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23: 907-922. (Pubitemid 34752946)
16. Hecht SS, Carmella SG, Murphy SE, Riley WT, Le C, Luo X, Mooney M, Hatsukami DK. (2007). Similar exposure to a tobacco-specifc carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomarkers Prev 16:1567-1572. (Pubitemid 47294820)
17. Hecht SS, Carmella SG, Stepanov I, Jensen J, Anderson A, Hatsukami DK. (2008). Metabolism of the tobacco-specifc carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users. Cancer Epidemiol Biomarkers Prev 17:732-735. (Pubitemid 351469228)
18. Hecht SS, Carmella SG, Ye M, Le KA, Jensen JA, Zimmerman CL, Hatsukami DK. (2002). Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)- 1-butanone after cessation of smokeless tobacco use. Cancer Res 62:129-134. (Pubitemid 34073996)
19. Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, Duell EJ. (2009). Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect 117:1718-1723.
20. Heudorf U, Angerer J. (2001). Urinary monohydroxylated phenanthrenes and hydroxypyrene-the efects of smoking habits and changes induced by smoking on monooxygenase-mediated metabolism. Int Arch Occup Environ Health 74:177-183. (Pubitemid 32377454)
21. Hofmann D, Adams JD, Lisk D, Fisenne I, Brunnemann KD. (1987). Toxic and carcinogenic agents in dry and moist snuf. J Natl Cancer Inst 79:1281-1286. (Pubitemid 18036733)
22. IARC. (2004). Tobacco and Involuntary Smoking. IARC Monogr Eval Carcinog Risks Hum 83:1452.
23. IARC. (2007). Smokeless tobacco and some tobacco-specifc N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum 89:626.
24. Jacob J, Grimmer G, Dettbarn G (1999). Profle of urinary phenanthrene metabolites in smokers and non-smokers. Biomarkers 4:319-327. (Pubitemid 29482957)
25. Kafai MR, Ganji V. (2003). Sex, age, geographical location, smoking, and alcohol consumption infuence serum selenium concentrations in the USA: third National Health and Nutrition Examination Survey, 1988-1994. J Trace Elem Med Biol 17:13-18. (Pubitemid 36538167)
26. Kresty LA, Carmella SG, Borukhova A, Akerkar SA, Gopalakrishnan R, Harris RE, Stoner GD, Hecht SS. (1996). Metabolites of a tobacco-specifc nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia. Cancer Epidemiol Biomarkers Prev 5:521-525. (Pubitemid 26235018)
27. Lee DH, Jacobs DR, Kocher T (2008). Associations of serum concentrations of persistent organic pollutants with the prevalence of periodontal disease and subpopulations of white blood cells. Environ Health Perspect 116:1558-1562.
28. Lin YS, Egeghy PP, Rappaport SM. (2008). Relationships between levels of volatile organic compounds in air and blood from the general population. J Expo Sci Environ Epidemiol 18:421-429. (Pubitemid 351861559)
29. Lumley T.(2010). R package version 3.22-1. Survey: analysis of complex survey samples. Available at: http://faculty.washington.edu/tlumley/survey/ [accessed March 2010]
30. Maier RH, Bray JT, Pories WJ. (1989). Trace element status of some commercial smokeless tobaccos. J Toxicol Environ Health 28:171-181. (Pubitemid 19264066)
31. Manini P, De Palma G, Andreoli R, Poli D, Mozzoni P, Folesani G, Mutti A, Apostoli P. (2006). Environmental and biological monitoring of benzene exposure in a cohort of Italian taxi drivers. Toxicol Lett 167:142-151. (Pubitemid 44751379)
32. Manini P, De Palma G, Andreoli R, Poli D, Petyx M, Corradi M, Mutti A, Apostoli P. (2008). Biological monitoring of low benzene exposure in Italian trafc policemen. Toxicol Lett 181:25-30.
33. Mannino DM, Homa DM, Matte T, Hernandez-Avila M. (2005). Active and passive smoking and blood lead levels in U.S. adults: data from the Tird National Health and Nutrition Examination Survey. Nicotine Tob Res 7:557-564. (Pubitemid 41600914)
34. McKelvey W, Gwynn RC, Jefery N, Kass D, Torpe LE, Garg RK, Palmer CD, Parsons PJ. (2007). A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults. Environ Health Perspect 115:1435-1441. (Pubitemid 47618085)
35. Murphy SE, Link CA, Jensen J, Le C, Puumala SS, Hecht SS, Carmella SG, Losey L, Hatsukami DK. (2004). A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers. Cancer Epidemiol Biomarkers Prev 13:1617-1623. (Pubitemid 39331883)
36. Nan HM, Kim H, Lim HS, Choi JK, Kawamoto T, Kang JW, Lee CH, Kim YD, Kwon EH. (2001). Efects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations. Carcinogenesis 22:787-793. (Pubitemid 32447927)
37. NCI (National Cancer Institute). (1999). Health efects of exposure to environmental tobacco smoke (Smoking and Tobacco Control Monograph no. 10). Bethesda, MD: National Cancer Institute. Available at: http://cancercontrol. cancer.gov/tcrb/monographs/10/[accessed May 2010]
38. Pappas RS, Stanfll SB, Watson CH, Ashley DL. (2008). Analysis of toxic metals in commercial moist snuf and Alaskan iqmik. J Anal Toxicol 32:281-291. (Pubitemid 351679818)
39. Pérez HL, Osterman-Golkar S. (2003). A sensitive gas chromatographic-tandem mass spectrometric method for detection of alkylating agents in water: application to acrylamide in drinking water, cofee and snuf. Analyst 128:1033-1036. (Pubitemid 37026261)
40. Richter PA, Bishop EE, Wang J, Swahn MH. (2009). Tobacco smoke exposure and levels of urinary metals in the U.S. youth and adult population: the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Int J Environ Res Public Health 6:1930-1946.
41. Rodgman A, Perfetti TA.(2009). Te chemical components of tobacco and tobacco smoke. Boca Raton, FL: Taylor & Francis.
42. Roethig HJ, Munjal S, Feng S, Liang Q, Sarkar M, Walk RA, Mendes PE. (2009). Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers. Nicotine Tob Res 11:1216-1225.
43. Santamaria A, Ferriby L, Harris M, Paustenbach D. (2006). Use of Biomarkers in Health Risk Assessment. In: DeCaprio AP, editor. Toxicologic biomarkers. New York: Taylor & Francis, xii, 295 p.
44. Scherer G. (2005). Biomonitoring of inhaled complex mixtures-ambient air, diesel exhaust and cigarette smoke. Exp Toxicol Pathol 57 Suppl 1:75-110. (Pubitemid 40884484)
45. Scherer G, Frank S, Riedel K, Meger-Kossien I, Renner T (2000). Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiol Biomarkers Prev 9:373-380. (Pubitemid 30265780)
46. Sexton K. (2006). Biomarkers of Toxicant Exposure. In: DeCaprio AP, editor. Toxicologic biomarkers. New York: Taylor & Francis, xii, 295 p.
47. Shaham J, Meltzer A, Ashkenazi R, Ribak J. (1996). Biological monitoring of exposure to cadmium, a human carcinogen, as a result of active and passive smoking. J Occup Environ Med 38:1220-1228. (Pubitemid 27016589)
48. Smith KM, Barraj LM, Kantor M, Sahyoun NR. (2009). Relationship between fsh intake, n-3 fatty acids, mercury and risk markers of CHD (National Health and Nutrition Examination Survey 1999-2002). Public Health Nutr 12:1261-1269.
49. Stepanov I, Upadhyaya P, Carmella SG, Feuer R, Jensen J, Hatsukami DK, Hecht SS. (2008). Extensive metabolic activation of the tobacco-specifc carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers. Cancer Epidemiol Biomarkers Prev 17:1764-1773.
50. Stepanov I, Villalta PW, Knezevich A, Jensen J, Hatsukami D, Hecht SS. (2010). Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry. Chem Res Toxicol 23:66-73.
51. Vesper HW, Bernert JT, Ospina M, Meyers T, Ingham L, Smith A, Myers GL. (2007). Assessment of the relation between biomarkers for smoking and biomarkers for acrylamide exposure in humans. Cancer Epidemiol Biomarkers Prev 16:2471-2478. (Pubitemid 351196383)
52. Vesper HW, Caudill SP, Osterloh JD, Meyers T, Scott D, Myers GL. (2010). Exposure of the U.S. population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004. Environ Health Perspect 118:278-283.
53. Wei W, Kim Y Boudreau N (2001). Association of smoking with serum and dietary levels of antioxidants in adults: NHANES III, 1988-1994. Am J Public Health 91:258-264. (Pubitemid 32113185)
54. Willers S, Attewell R, Bensryd I, Schutz A, Skarping G, Vahter M. (1992). Exposure to environmental tobacco smoke in the household and urinary cotinine excretion, heavy metals retention, and lung function. Arch Environ Health 47:357-363.
55. Wilson CL, Bodnar JA, Brown BG, Morgan WT, Potts RJ, Borgerding MF. (2008). Assessment of dioxin and dioxin-like compounds in mainstream smoke from selected US cigarette brands and reference cigarettes. Food Chem Toxicol 46:1721-1733.
56. Yang M, Koga M, Katoh T, Kawamoto T (1999). A study for the proper application of urinary naphthols, new biomarkers for airborne polycyclic aromatic hydrocarbons. Arch Environ Contam Toxicol 36:99-108. (Pubitemid 28565493)